Cinctive Capital Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-22,936
Closed -$1.11M 544
2026
Q1
$1.11M Buy
+22,936
New +$1.07M 0.07% 245
2025
Q2
Sell
-54,394
Closed -$3.02M 468
2025
Q1
$3.02M Sell
54,394
-53,923
-50% -$2.92M 0.23% 130
2024
Q4
$5.22M Sell
108,317
-46,792
-30% -$2.38M 0.27% 128
2024
Q3
$8.94M Buy
155,109
+80,033
+107% +$4.32M 0.49% 64
2024
Q2
$3.64M Sell
75,076
-5,307
-7% -$256K 0.17% 181
2024
Q1
$3.91M Buy
+80,383
New +$3.93M 0.18% 154
2023
Q3
Sell
-157,362
Closed -$8.48M 474
2023
Q2
$8.48M Buy
+157,362
New +$8.47M 0.28% 128
2023
Q1
Sell
-179,788
Closed -$8.71M 513
2022
Q4
$8.71M Buy
+179,788
New +$7.89M 0.43% 76
2022
Q3
Sell
-178,509
Closed -$8.93M 599
2022
Q2
$8.93M Buy
+178,509
New +$9.48M 0.38% 84

Other funds holding SNY

Cinctive Capital Management's SNY Position: Q2 2026 in Review

Cinctive Capital Management sold out of Sanofi (SNY) in Q2 2026, closing a stake of 22,936 shares — an estimated $1.11M sold.

Cinctive Capital Management first reported a position in SNY in Q2 2022 and held it in 9 quarters. The position peaked at $8.94M in Q3 2024. 716 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Cinctive Capital Management reported no remaining Sanofi position as of Q2 2026 after selling out during the quarter.
  • Cinctive Capital Management sold 22,936 Sanofi shares in Q2 2026, an estimated $1.11M.
  • Cinctive Capital Management first reported a position in Sanofi in Q2 2022 and held it in 9 quarters.
  • Cinctive Capital Management's Sanofi position peaked at $8.94M in Q3 2024.
  • 716 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Cinctive Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.